Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,585) Arrow Down
Filter Results: (1,585) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,585)
    • People  (7)
    • News  (501)
    • Research  (784)
    • Events  (3)
    • Multimedia  (10)
  • Faculty Publications  (379)

Show Results For

  • All HBS Web  (1,585)
    • People  (7)
    • News  (501)
    • Research  (784)
    • Events  (3)
    • Multimedia  (10)
  • Faculty Publications  (379)
← Page 11 of 1,585 Results →
  • October 2021 (Revised January 2022)
  • Supplement

Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)

By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Citation
Purchase
Related
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
  • February 2015 (Revised November 2015)
  • Supplement

Building an Integrated Biopharma Company: Crucell (B)

By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing Agreements In Biopharmacy; Licensing; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Entrepreneurship; Health Care and Treatment; Acquisition; Innovation and Invention; Biotechnology Industry; Pharmaceutical Industry
Citation
Purchase
Related
Hamermesh, Richard G., Marianne Van Der Steen, and Susan Harmeling. "Building an Integrated Biopharma Company: Crucell (B)." Harvard Business School Supplement 815-086, February 2015. (Revised November 2015.)
  • 16 Mar 2017
  • News

The CEO Who's Turning the Global Development Movement on Its Head

  • 09 Jun 2020
  • News

In a Pandemic, What’s the Best Strategy for the Global Vaccine Alliance?

  • 16 Nov 2021
  • News

Getting Back Together for Global Networking Night; Healthcare Conference Draws New Interest

Clubs News Clubs News Reconnecting and Reimagining the Future at Global Networking Night The 2021 HBS Global Networking Night (GNN), held on October 20, celebrated 55 global... View Details
Keywords: Margie Kelley
  • Web

Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement

Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship View Details
  • October 2019 (Revised December 2019)
  • Case

La Roche-Posay: Growing L'Oreal's Active Cosmetics Brand

By: Jill Avery, Vincent Dessain and Mette Fuglsang Hjortshoej
As 2018 neared its end, Laetitia Toupet, international general manager of L’Oréal’s La Roche-Posay brand reflected on the brand’s achievements over the past year. At €1 billion in revenue, La Roche-Posay had recently become the number one dermocosmetics brand in the... View Details
Keywords: Branding; Brand Management; Consumer Products; Brand Positioning; Target Market; Global Brands; Global Marketing; Marketing; Marketing Strategy; Brands and Branding; Globalized Firms and Management; Health Industry; Health Industry; Health Industry; France; Europe; Brazil; China; Asia; South America; United States; North America
Citation
Educators
Purchase
Related
Avery, Jill, Vincent Dessain, and Mette Fuglsang Hjortshoej. "La Roche-Posay: Growing L'Oreal's Active Cosmetics Brand." Harvard Business School Case 520-035, October 2019. (Revised December 2019.)
  • May 2009
  • Teaching Note

The World Food Programme during the Global Food Crisis (TN) (A) and (B)

By: Eric D. Werker
Teaching Note for [709024] and [709052]. View Details
Keywords: Non-Governmental Organizations; Nutrition; Food; Crisis Management; Problems and Challenges; Poverty
Citation
Purchase
Related
Werker, Eric D. "The World Food Programme during the Global Food Crisis (TN) (A) and (B)." Harvard Business School Teaching Note 709-053, May 2009.
  • Web

Helping and harnessing business to address society’s greatest challenges. | Institute for Business in Global Society

Initiative With global health care spending greater than $8.5 trillion, there is no shortage of opportunities to make an impact in this demanding sector. Leadership Initiative Leaders have always faced the... View Details
  • January 2022
  • Article

Global Behaviors, Perceptions, and the Emergence of Social Norms at the Onset of the COVID-19 Pandemic

By: Lukas Hensel, Marc Witte, Stefano Caria, Thiemo Fetzer, Stefano Fiorin, Friedrich M. Goetz, Margarita Gomez, Johannes Haushofer, Andriy Ivchenko, Gordon T. Kraft-Todd, Elena Reutskaja, Christopher Roth, Erez Yoeli and Jon M. Jachimowicz
We conducted a large-scale survey covering 58 countries and over 100,000 respondents between late March and early April 2020 to study beliefs and attitudes towards citizens' and governments' responses at the onset of the COVID-19 pandemic. Most respondents reported... View Details
Keywords: COVID-19; Government Regulation; Social Norms; Health Pandemics; Governing Rules, Regulations, and Reforms; Behavior; Perception; Global Range; Surveys
Citation
Find at Harvard
Read Now
Related
Hensel, Lukas, Marc Witte, Stefano Caria, Thiemo Fetzer, Stefano Fiorin, Friedrich M. Goetz, Margarita Gomez, Johannes Haushofer, Andriy Ivchenko, Gordon T. Kraft-Todd, Elena Reutskaja, Christopher Roth, Erez Yoeli, and Jon M. Jachimowicz. "Global Behaviors, Perceptions, and the Emergence of Social Norms at the Onset of the COVID-19 Pandemic." Journal of Economic Behavior & Organization 193 (January 2022): 473–496.
  • September 2020
  • Article

Regulatory Sandboxes: A Cure for mHealth Pilotitis?

By: Abhishek Bhatia, Rahul Matthan, Tarun Khanna and Satchit Balsari
Mobile health (mHealth) and related digital health interventions in the past decade have not always scaled globally as anticipated earlier despite large investments by governments and philanthropic foundations. The implementation of digital health tools has suffered... View Details
Keywords: COVID-19; mHealth; Digital Health; Design Thinking; Regulation; Intervention; Regulatory Sandbox; Health Care and Treatment; Technological Innovation; Design; Governing Rules, Regulations, and Reforms; India
Citation
Read Now
Related
Bhatia, Abhishek, Rahul Matthan, Tarun Khanna, and Satchit Balsari. "Regulatory Sandboxes: A Cure for mHealth Pilotitis?" Journal of Medical Internet Research 22, no. 9 (September 2020).
  • February 2015 (Revised November 2015)
  • Case

Building an Integrated Biopharma Company: Crucell (A)

By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing; Licensing Agreements In Biopharmacy; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Partners and Partnerships; Entrepreneurship; Growth and Development Strategy; Biotechnology Industry; Pharmaceutical Industry; Netherlands
Citation
Educators
Purchase
Related
Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)
  • Web

Student Spotlight: From Nigeria to HBS: Reigniting My Passion for Healthcare Innovation - Blog: Health Supplement

Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship View Details
  • 23 Jun 2020
  • Working Paper Summaries

Dignity, Inequality, and the Populist Backlash: Lessons from America and Europe for a Sustainable Globalization

Keywords: by Rawi Abdelal
  • April 8, 2025
  • Article

Creating Workplaces Free of Forever Chemicals

By: Joseph G. Allen, Heather A. Henrikson and Michael W. Toffel
Forever chemicals are toxic and widely used in buildings and yet they remain on the rise globally with little regulation to control them. In the United States, for example, Environmental Protection Agency (EPA) regulations currently cover only forever chemicals in... View Details
Keywords: Occupational Health; Safety Regulations; Regulation; Working Conditions; Governing Rules, Regulations, and Reforms; Safety; Health
Citation
Read Now
Related
Allen, Joseph G., Heather A. Henrikson, and Michael W. Toffel. "Creating Workplaces Free of Forever Chemicals." Harvard Business Review Digital Articles (April 8, 2025).
  • September–October 2020
  • Article

Global Supply Chains in a Post-Pandemic World: Companies Need to Make Their Networks More Resilient. Here's How.

By: Willy C. Shih
The COVID-19 pandemic exposed the vulnerabilities in the production strategies and supply chains of firms everywhere. Coupled with a rise in economic nationalism, manufacturers everywhere are going to be under pressure to rethink their sourcing and logistics... View Details
Keywords: Resilience; Pandemic; Operations Management; Health Pandemics; Supply Chain; Supply Chain Management; Manufacturing Industry; United States; Asia; Europe
Citation
Find at Harvard
Register to Read
Related
Shih, Willy C. "Global Supply Chains in a Post-Pandemic World: Companies Need to Make Their Networks More Resilient. Here's How." R2005F. Harvard Business Review 98, no. 5 (September–October 2020): 82–89.
  • May 2014 (Revised March 2017)
  • Case

Unilever's Lifebuoy in India: Implementing the Sustainability Plan

By: Christopher A. Bartlett

Unilever's new Global Brand VP must not only revitalize Lifebuoy soap's sagging market performance, but simultaneously impact the health of one billion people worldwide. The latter challenge comes from Unilever's new CEO who has introduced the Unilever Sustainable... View Details

Keywords: Multinational Management; Corporate Social Responsibility; Strategy Implementation; Marketing Strategy; Mission And Purpose; Change Management; International Business; Global; Fast-moving Consumer Goods; Soap; Corporate Social Responsibility and Impact; Health Care and Treatment; Environmental Sustainability; Global Strategy; Developing Countries and Economies; Beauty and Cosmetics Industry; Health Industry; India
Citation
Educators
Purchase
Related
Bartlett, Christopher A. "Unilever's Lifebuoy in India: Implementing the Sustainability Plan." Harvard Business School Case 914-417, May 2014. (Revised March 2017.)
  • Web

THE VALUE OF THE PHYSICIAN SHADOW PROGRAM: Witnessing The Front Lines of Care Delivery - Blog: Health Supplement

Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship View Details
  • May 2015 (Revised May 2017)
  • Case

Colgate-Palmolive Company: Marketing Anti-Cavity Toothpaste

By: John A. Quelch and Margaret L. Rodriguez
In October 2013, Colgate-Palmolive Company, the world's leading oral care company, was about to launch its new Colgate® Maximum Cavity Protection™ plus Sugar Acid Neutralizer™ toothpaste in Brazil. Oral care category accounted for 46 percent of Colgate's $17.4 billion... View Details
Keywords: New Product Management; Consumer Segmentation; Global Marketing; Corporate Social Responsibility; Healthcare; Sustainability; Health Care and Treatment; Environmental Sustainability; Marketing; Segmentation; Product Development; Product Launch; Corporate Social Responsibility and Impact; Product Positioning; Consumer Products Industry; Brazil; United States
Citation
Educators
Purchase
Related
Quelch, John A., and Margaret L. Rodriguez. "Colgate-Palmolive Company: Marketing Anti-Cavity Toothpaste." Harvard Business School Case 515-050, May 2015. (Revised May 2017.)
  • Teaching Interest

Business Opportunties in Climate Adaptation

By: John D. Macomber

This is a Short Intensive Program or SIP at Harvard Business School.  It’s an optional student offering prior to the formal start of the Spring semester the following week.  SIPs tend to cover new material on current topics, to be less formal than the HBS Case Study... View Details

Keywords: Resilience; Climate Risk; Climate Impact; Fire Protection; Insurance Risk Exposure; Hedge Fund; Public Health; Public Health Measures; Climate Change; Adaptation; Infrastructure; Real Estate Industry; Transportation Industry; Insurance Industry; United States; Africa; Latin America
  • ←
  • 11
  • 12
  • …
  • 79
  • 80
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.